Results 41 to 50 of about 3,074 (167)
DISCONTINUATION RATES FOLLOWING A SWITCH FROM A REFERENCE TO A BIOSIMILAR BIOLOGIC IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS [PDF]
BACKGROUND: Biologics have revolutionized the treatment of inflammatory bowel disease (IBD). However, these drugs had a significant influence on treatment-related costs, which resulted in the development of biosimilars.
Natália Sousa Freitas QUEIROZ +6 more
doaj +1 more source
PO104 Placebo and nocebo responses in rls: a meta-analysis [PDF]
Objective Our goals were to estimate the placebo and nocebo responses in restless legs syndrome (RLS). Methods Databases were searched up to October 2015. Randomised, double-blind, placebo-controlled trials of RLS patient were included. ‘Placebo response’ was defined as the within-group change from baseline, using any scale measuring RLS severity or
Rodrigues, Filipe Brogueira +8 more
openaire +2 more sources
A placebo effect is a positive clinical response to non-specific elements of treatment with a sham or inert replica of a drug, device, or surgical intervention. There is considerable evidence that placebo effects are driven by expectation of benefit from
Hailey E. Yetman +6 more
doaj +1 more source
Qualitative StuNocebo Phenomenon (NP) Involved in Doctor-Patient Communication [PDF]
Background Doctor-patient communication has far reaching influences on the overall well-being of the patients. Words are powerful tools in the doctor’s armamentarium, having both healing as well as harming effects.
Bushra Ashraf +2 more
doaj +1 more source
Background Adverse events of chemotherapy may be caused by pharmacodynamics or psychological factors such as negative expectations, which constitute nocebo effects. In a randomized controlled trial, we examined whether educating patients about the nocebo
T. Michnevich +5 more
doaj +1 more source
The act of nonmedical switching, defined as switching stable patients who are generally doing well with their current therapy from an originator biologic to its biosimilar, has been endorsed as a reasonable treatment strategy.
Roy Fleischmann +4 more
doaj +1 more source
Background: Conditioning is a key mechanism of placebo and nocebo effects in adults. Little is known about the underlying mechanisms of placebo and nocebo effects in youth and how they might be influenced by conscious awareness and cognitive abilities ...
Regula Neuenschwander +5 more
doaj +1 more source
How the number of learning trials affects placebo and nocebo responses [PDF]
Conditioning procedures are used in many placebo studies because evidence suggests that conditioning-related placebo responses are usually more robust than those induced by verbal suggestions alone. However, it has not been shown whether there is a causal relation between the number of conditioning trials and the resistance to extinction of placebo and
Colloca L +4 more
openaire +3 more sources
No Reason to Feel Sick? Nocebo Responses in the Placebo Arms of Experimental Endotoxemia Studies
Adverse side effects are reported by a large proportion of patients undergoing medical treatment in clinical practice or clinical trials. Nocebo effects, induced by negative treatment expectancies, can contribute to negative patient-reported outcomes but
Sven Benson, Sigrid Elsenbruch
doaj +1 more source
Does electromagnetic hypersensitivity originate from nocebo responses? Indications from a qualitative study [PDF]
Idiopathic Environmental Intolerance attributed to Electromagnetic Fields (IEI‐EMF) is a condition in which symptoms are attributed to electromagnetic field (EMF) exposure. As electro‐hypersensitive (EHS) people have repeatedly been observed, during provocation trials, to report symptoms following perceived rather than actual exposure, the hypothesis ...
openaire +3 more sources

